Regondi, Viola

Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer

Di Modica, M., Gargari, G., Regondi, V., Bonizzi, A., Arioli, S., Belmonte, B., De Cecco, L., Fasano, E., Bianchi, F., Bertolotti, A., et al. (2021) · Cancer Research

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 184

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit

Triulzi, T., Regondi, V., De Cecco, L., Cappelletti, M. R., Di Modica, M., Paolini, B., Lollini, P. L., Di Cosimo, S., Sfondrini, L., Generali, D., et al. (2018) · British Journal of Cancer

HER2/EGFR in Cancer ResearchCancer Immunotherapy and Biomarkers

Cited by 94